Andrew P Riley

Title: Innovations and Contributions of Andrew P. Riley

Introduction

Andrew P. Riley is a notable inventor based in Urbana, Illinois, recognized for his significant contributions to the field of antimicrobial treatments and cancer research. With a total of three patents to his name, Riley's work focuses on developing novel compounds that target gram-negative bacteria and exploring their potential in anticancer therapies.

Latest Patents

Riley's latest patents include groundbreaking research on small molecules active against gram-negative bacteria. These patents disclose novel compounds that accumulate in gram-negative bacteria, along with methods for antimicrobial treatment using these compounds. Another significant patent involves topoisomerase inhibitors with antibacterial and anticancer activity. This patent describes the conversion of deoxynybomycin (DNM), a natural product and DNA gyrase inhibitor, into a compound that exhibits anticancer activity. Detailed in vitro and cell culture experiments demonstrate that these compounds inhibit Top2 and also act upon topoisomerase I, showcasing their potential for discovering new anticancer drugs.

Career Highlights

Andrew P. Riley is affiliated with the University of Illinois, where he conducts his research and development work. His innovative approach to tackling bacterial infections and cancer has positioned him as a key figure in his field.

Collaborations

Riley collaborates with esteemed colleagues such as Paul Joseph Hergenrother and Michelle Richter, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Andrew P. Riley's work exemplifies the intersection of innovation and practical application in the fields of antimicrobial and anticancer research. His contributions continue to pave the way for advancements in medical treatments and therapies.